Susquehanna International Group’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $16.7M | Sell |
|
|||||
|
2025
Q2 | $41.2M | Sell |
|
|||||
|
2025
Q1 | $55.8M | Buy |
|
|||||
|
2024
Q4 | $1.29M | Sell |
|
|||||
|
2024
Q3 | $9.48M | Buy |
|
|||||
|
2024
Q2 | $1.49M | Sell |
|
|||||
|
2024
Q1 | $15.4M | Buy |
|
|||||
|
2023
Q4 | $1.64M | Sell |
|
|||||
|
2023
Q3 | $12.8M | Sell |
|
|||||
|
2023
Q2 | $28.4M | Buy |
|
|||||
|
2023
Q1 | $27.7M | Sell |
|
|||||
|
2022
Q4 | $29.8M | Buy |
|
|||||
|
2022
Q3 | $26M | Sell |
|
|||||
|
2022
Q2 | $34.5M | Sell |
|
|||||
|
2022
Q1 | $54M | Sell |
|
|||||
|
2021
Q4 | $87.6M | Buy |
|
|||||
|
2021
Q3 | $106M | Buy |
|
|||||
|
2021
Q2 | $104M | Buy |
|
|||||
|
2021
Q1 | $98.7M | Buy |
|
|||||
|
2020
Q4 | $67.1M | Buy |
|
|||||
|
2020
Q3 | $40.6M | Sell |
|
|||||
|
2020
Q2 | $94.2M | Buy |
|
|||||
|
2020
Q1 | $59.1M | Sell |
|
|||||
|
2019
Q4 | $65.4M | Buy |
|
|||||
|
2019
Q3 | $42.5M | Buy |
|
|||||
|
2019
Q2 | $44.9M | Buy |
|
|||||
|
2019
Q1 | $53.5M | Buy |
|
|||||
|
2018
Q4 | – | Hold |
|
|||||
|
2018
Q3 | – | Hold |
|
|||||
|
2018
Q2 | – | Sell |
|
|||||
|
2018
Q1 | $7.82M | Sell |
|
|||||
|
2017
Q4 | $20M | Sell |
|
|||||
|
2017
Q3 | $114M | Buy |
|
|||||
|
2017
Q2 | $102M | Sell |
|
|||||
|
2017
Q1 | $120M | Sell |
|
|||||
|
2016
Q4 | $137M | Buy |
|
|||||
|
2016
Q3 | $154M | Buy |
|
|||||
|
2016
Q2 | $111M | Buy |
|
|||||
|
2016
Q1 | $86.8M | Buy |
|
|||||
|
2015
Q4 | $15.4M | Sell |
|
|||||
|
2015
Q3 | $61.6M | Sell |
|
|||||
|
2015
Q2 | $83.5M | Buy |
|
|||||
|
2015
Q1 | $30.2M | Buy |
|
|||||
|
2014
Q4 | $6.05M | Sell |
|
|||||
|
2014
Q3 | $70.3M | Buy |
|
|||||
|
2014
Q2 | $52.7M | Sell |
|
|||||
|
2014
Q1 | $140M | Sell |
|
|||||
|
2013
Q4 | $150M | Buy |
|
|||||
|
2013
Q3 | $103M | Buy |
|
|||||
|
2013
Q2 | $97.6M | Buy |
|